BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$4.89B |
| 2 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$2.11B |
| 3 |
Cigna
CI
|
+$2.09B |
| 4 |
ExxonMobil
XOM
|
+$1.33B |
| 5 |
Verizon
VZ
|
+$1.32B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$4.73B |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$3.38B |
| 3 |
PX
Praxair Inc
PX
|
+$2.8B |
| 4 |
iShares Russell 1000 ETF
IWB
|
+$2.28B |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$2.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.96% |
| 2 | Healthcare | 14.79% |
| 3 | Financials | 14.43% |
| 4 | Consumer Discretionary | 9.82% |
| 5 | Industrials | 9.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Sutro Biopharma
STRO
$421M
| $3.7M | ﹤0.01% |
40,971
+6,981
| +21% | +$843K |
|
|
RVLP
3477
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $3.68M | ﹤0.01% |
+475,079
| New | +$3.8M |
|
3478
iShares US Consumer Focused ETF
IEDI
$28.7M
| $3.66M | ﹤0.01% |
150,000
| – | – |
|
|
CYBE
3479
DELISTED
Cyberoptics Corp
CYBE
| $3.63M | ﹤0.01% |
205,811
-230
| -0.1% | -$4.35K |
|
3480
iShares Core S&P US Growth ETF
IUSG
$33.9B
| $3.62M | ﹤0.01% |
68,757
+24,269
| +55% | +$1.38M |
|
|
JNCE
3481
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $3.59M | ﹤0.01% |
1,065,339
-385,341
| -27% | -$1.8M |
|
3482
Carlyle Secured Lending
CGBD
$758M
| $3.59M | ﹤0.01% |
289,487
-14,882
| -5% | -$226K |
|
3483
Fennec Pharmaceuticals
FENC
$402M
| $3.59M | ﹤0.01% |
562,216
+2,429
| +0.4% | +$17K |
|
3484
Asure Software
ASUR
$250M
| $3.58M | ﹤0.01% |
705,365
-337
| -0% | -$2.78K |
|
|
IO
3485
DELISTED
ION Geophysical Corporation
IO
| $3.54M | ﹤0.01% |
684,297
-2,159
| -0.3% | -$21.9K |
|
3486
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.81B
| $3.54M | ﹤0.01% |
41,517
+787
| +2% | +$66.8K |
|
|
CWBR
3487
DELISTED
CohBar, Inc. Common Stock
CWBR
| $3.54M | ﹤0.01% |
37,893
+307
| +0.8% | +$34.1K |
|
3488
State Street SPDR Portfolio Long Term Corporate Bond ETF
SPLB
$1.19B
| $3.52M | ﹤0.01% |
138,588
+2,296
| +2% | +$58.1K |
|
|
EDN
3489
Edenor
EDN
$1.06B
| $3.5M | ﹤0.01% |
129,517
-7,747
| -6% | -$190K |
|
3490
BlackRock TCP Capital
TCPC
$345M
| $3.49M | ﹤0.01% |
267,976
-12,100
| -4% | -$169K |
|
3491
iShares US Small Cap Equity Factor ETF
SMLF
$4.3B
| $3.49M | ﹤0.01% |
97,314
+13,266
| +16% | +$521K |
|
3492
inTEST
INTT
$177M
| $3.47M | ﹤0.01% |
566,717
+11,479
| +2% | +$78.6K |
|
3493
Corvus Pharmaceuticals
CRVS
$1.17B
| $3.47M | ﹤0.01% |
946,378
-260,142
| -22% | -$1.77M |
|
3494
PUT
Tesla
TSLA
$1.3T
| $3.43M | ﹤0.01% |
+154,500
| New | +$3.32M |
|
3495
CorMedix
CRMD
$584M
| $3.43M | ﹤0.01% |
531,334
+419,332
| +374% | +$2.8M |
|
3496
Ovid Therapeutics
OVID
$491M
| $3.42M | ﹤0.01% |
1,414,696
-73,059
| -5% | -$333K |
|
3497
Auburn National Bancorp
AUBN
$91.9M
| $3.42M | ﹤0.01% |
107,902
+3,361
| +3% | +$126K |
|
3498
Capital Bancorp
CBNK
$615M
| $3.4M | ﹤0.01% |
+298,491
| New | +$3.71M |
|
|
JMEI
3499
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
| $3.4M | ﹤0.01% |
185,941
+23,067
| +14% | +$471K |
|
3500
iQIYI
IQ
$1.28B
| $3.4M | ﹤0.01% |
228,496
+206
| +0.1% | +$4.3K |
|
Similar funds
BlackRock's Q4 2018 Portfolio in Review
As of Q4 2018, BlackRock held 5,211 positions worth $1.98T, down 14% from $2.31T the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BlackRock's Q4 2018 filing shows 169 new, 3,017 increased, 1,308 reduced and 195 closed positions. Its largest new stake was Linde: 30,937,347 shares worth $4.83B. The largest sale was Aetna Inc, an estimated $4.73B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q4 2018 buy was Linde: 30,937,347 shares worth $4.83B.
- BlackRock added most to iShares Core MSCI Total International Stock ETF in Q4 2018, an estimated $2.11B increase.
- BlackRock's biggest Q4 2018 reduction was iShares Russell 1000 ETF, cutting an estimated $2.28B.
- BlackRock fully exited Aetna Inc in Q4 2018, selling an estimated $4.73B.
- BlackRock's ten largest holdings make up 14% of its $1.98T portfolio in Q4 2018.
- BlackRock opened 169 new positions and closed 195 in Q4 2018.
- BlackRock's portfolio value fell 14% quarter-over-quarter to $1.98T.
Based on BlackRock's 13F filing for Q4 2018, filed 8 Feb 2019.